Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice

Overview of attention for article published in Acta Neuropathologica Communications, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 69 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Design, Synthesis, and Biological Evaluation of Some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide Hybrids as MTDLs for Alzheimer’s Disease Therapy

Article in European Journal of Medicinal Chemistry (April 2024)

Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies

Article in Journal of Neurology (March 2024)

The interaction between mutated DYRK1A and APP suggests a potential target for vascular cognitive impairment

Conference proceeding (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.